Read + Share
Amedeo Smart
Independent Medical Education
Ta QD, Do C, Sharma K, Sorooshian HZ, et al. Reduced dosing of lenvatinib with pembrolizumab for advanced endometrial cancer. Gynecol Oncol 2025;196:36-41.PMID: 40174387
Email
LinkedIn
Privacy Policy